• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有和不伴有凝血因子V莱顿突变的白塞病患者的血栓调节蛋白水平

Thrombomodulin levels in Behçet's disease with and without the factor V Leiden mutation.

作者信息

Gürgey A, Gurler A, Oner A F, Mesci L, Kirazli S

机构信息

Department of Pediatric Hematology, Hacettepe University Faculty of Medicine, Ankara, Turkey.

出版信息

Clin Rheumatol. 1998;17(3):186-8. doi: 10.1007/BF01451044.

DOI:10.1007/BF01451044
PMID:9694049
Abstract

The plasma levels of thrombomodulin (TM) in 34 patients with Behçet's disease and 79 healthy control subjects were studied. Eight patients had the factor V Leiden (FVL) mutation. The TM level was significantly lower in patients with the FVL mutation than in patients without the mutation and in the healthy controls (p < 0.05 and p < 0.01). However, there was no difference in overall mean plasma TM concentration between the patients without the mutation and the healthy controls.

摘要

研究了34例白塞病患者和79例健康对照者的血浆血栓调节蛋白(TM)水平。8例患者存在因子V莱顿(FVL)突变。有FVL突变的患者的TM水平显著低于无突变的患者和健康对照者(p<0.05和p<0.01)。然而,无突变的患者与健康对照者之间的总体平均血浆TM浓度没有差异。

相似文献

1
Thrombomodulin levels in Behçet's disease with and without the factor V Leiden mutation.伴有和不伴有凝血因子V莱顿突变的白塞病患者的血栓调节蛋白水平
Clin Rheumatol. 1998;17(3):186-8. doi: 10.1007/BF01451044.
2
Plasma thrombomodulin levels in patients with Behçet's disease.
Rheumatol Int. 2003 May;23(3):130-3. doi: 10.1007/s00296-002-0258-z. Epub 2003 Feb 21.
3
Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin.白塞病中的血管受累:与血栓形成倾向因素、凝血激活及血栓调节蛋白的关系。
Am J Med. 2002 Jan;112(1):37-43. doi: 10.1016/s0002-9343(01)01048-8.
4
Factor V Leiden mutation in patients with Behçet's disease.白塞病患者的凝血因子V莱顿突变
J Rheumatol. 1998 Mar;25(3):496-8.
5
Association of factor V Leiden and prothrombin gene mutation with Behçet's disease.凝血因子V莱顿突变和凝血酶原基因突变与白塞病的关联。
Arch Dermatol Res. 2001 Nov;293(10):537-9. doi: 10.1007/pl00007469.
6
Factor V Leiden mutation does not correlate with retinal vascular occlusion in white patients with Behçet's disease.在患有白塞病的白人患者中,凝血因子V莱顿突变与视网膜血管阻塞无关。
Br J Ophthalmol. 2003 Aug;87(8):1048-9. doi: 10.1136/bjo.87.8.1048.
7
Association of factor V Leiden with Behçet's disease.
J Rheumatol. 1997 Nov;24(11):2196-8.
8
Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.因子V莱顿突变携带者及无已知血栓形成风险因素患者的静脉血栓栓塞;复发预测以及活化蛋白C-蛋白C抑制物复合物浓度和/或可溶性血栓调节蛋白抗原及活性
Thromb Res. 2007;121(2):145-51. doi: 10.1016/j.thromres.2007.03.020. Epub 2007 May 11.
9
Levels of circulating intercellular adhesion molecule-1 in patients with Behçet's disease.白塞病患者循环中细胞间黏附分子-1的水平。
Rheumatol Int. 2002 Jan;21(4):146-8. doi: 10.1007/s00296-001-0148-9.
10
Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis.意大利白塞病合并深静脉血栓形成患者的凝血因子V莱顿突变和凝血酶原基因G20210A突变
Arthritis Rheum. 2004 Apr 15;51(2):177-83. doi: 10.1002/art.20237.

引用本文的文献

1
Behçet's disease and thrombophilia.白塞病与易栓症
Ann Rheum Dis. 2001 Dec;60(12):1081-5. doi: 10.1136/ard.60.12.1081.

本文引用的文献

1
Factor V Leiden mutation in patients with Behçet's disease.白塞病患者的凝血因子V莱顿突变
J Rheumatol. 1998 Mar;25(3):496-8.
2
Elevated levels of soluble thrombomodulin in plasma from children with Arg 506 to Gln mutation in the factor V gene.因子V基因中存在从精氨酸506到谷氨酰胺突变的儿童血浆中可溶性血栓调节蛋白水平升高。
Eur J Haematol. 1997 Jan;58(1):51-5. doi: 10.1111/j.1600-0609.1997.tb01410.x.
3
Coagulation factor V gene mutation increases the risk of venous thrombosis in behçet's disease.
Br J Rheumatol. 1996 Nov;35(11):1178-80. doi: 10.1093/rheumatology/35.11.1178.
4
Circulating thrombomodulin as a clue of endothelial damage in Behçet's disease.循环血栓调节蛋白作为白塞病内皮损伤的线索。
Thromb Haemost. 1996 Jun;75(6):974-5.
5
Factor V Q 506 mutation in children with thrombosis.患有血栓形成的儿童中的凝血因子V Q506突变
Am J Hematol. 1996 Sep;53(1):37-9. doi: 10.1002/(SICI)1096-8652(199609)53:1<37::AID-AJH8>3.0.CO;2-6.
6
Resistance to activated protein C as a basis for venous thrombosis.对活化蛋白C的抵抗作为静脉血栓形成的基础。
N Engl J Med. 1994 Feb 24;330(8):517-22. doi: 10.1056/NEJM199402243300801.
7
Mutation in blood coagulation factor V associated with resistance to activated protein C.凝血因子V突变与活化蛋白C抵抗相关。
Nature. 1994 May 5;369(6475):64-7. doi: 10.1038/369064a0.
8
Structure and function of thrombomodulin: a natural anticoagulant.血栓调节蛋白的结构与功能:一种天然抗凝剂。
Blood. 1990 Jan 15;75(2):329-36.
9
Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease.白塞病诊断标准。白塞病国际研究小组。
Lancet. 1990 May 5;335(8697):1078-80.